TY - JOUR
T1 - Hydrophobic ion pairing enables co-loading of water-soluble drugs in polymeric micelles
AU - Shalmani, Armin Azadkhah
AU - Daware, Rasika
AU - Elshafei, Asmaa Said
AU - De Lorenzi, Federica
AU - Moeckel, Diana
AU - Buhl, Eva M.
AU - Klinkhammer, Barbara Mara
AU - Boor, Peter
AU - Banala, Srinivas
AU - Adams, Alina
AU - Kiessling, Fabian
AU - Storm, Gert
AU - Metselaar, Josbert M.
AU - Sofias, Alexandros Marios
AU - Shi, Yang
AU - Lammers, Twan
AU - Peña, Quim
AU - Ojha, Tarun
N1 - Publisher Copyright:
© 2025 The Authors
PY - 2025/6/10
Y1 - 2025/6/10
N2 - Polymeric micelles are widely used for the delivery of hydrophobic drugs. However, several highly potent and ubiquitously used anticancer drugs are water-soluble, complicating their (co-)formulation in polymeric micelles without having to chemically modify them. We here explore hydrophobic ion pairing to enable the co-delivery of the water-soluble anthracycline chemotherapy drug doxorubicin and the angiotensin II receptor antagonist telmisartan (a clinically used antihypertensive drug that has shown promising (pre-) clinical outcomes in combination with anthracyclines). We show that hydrophobic ion pairing of doxorubicin and telmisartan promotes the co-encapsulation of both drugs in π electron-stabilized [PEG-b-p(HPMAm-Bz)]-based polymeric micelles. The cytotoxic activity of doxorubicin is retained, and the dual drug-loaded micelles display enhanced antitumor activity in vivo as compared to the combination of the free drugs, while also exhibiting good tolerability. Taken together, this work provides proof-of-concept for hydrophobic ion pairing as a promising formulation strategy to promote multidrug nanomedicine and drug combination therapy.
AB - Polymeric micelles are widely used for the delivery of hydrophobic drugs. However, several highly potent and ubiquitously used anticancer drugs are water-soluble, complicating their (co-)formulation in polymeric micelles without having to chemically modify them. We here explore hydrophobic ion pairing to enable the co-delivery of the water-soluble anthracycline chemotherapy drug doxorubicin and the angiotensin II receptor antagonist telmisartan (a clinically used antihypertensive drug that has shown promising (pre-) clinical outcomes in combination with anthracyclines). We show that hydrophobic ion pairing of doxorubicin and telmisartan promotes the co-encapsulation of both drugs in π electron-stabilized [PEG-b-p(HPMAm-Bz)]-based polymeric micelles. The cytotoxic activity of doxorubicin is retained, and the dual drug-loaded micelles display enhanced antitumor activity in vivo as compared to the combination of the free drugs, while also exhibiting good tolerability. Taken together, this work provides proof-of-concept for hydrophobic ion pairing as a promising formulation strategy to promote multidrug nanomedicine and drug combination therapy.
KW - Cancer
KW - Combination therapy
KW - Doxorubicin
KW - Hydrophobic ion pairing
KW - Multidrug nanomedicine
KW - Polymeric micelle
UR - http://www.scopus.com/inward/record.url?scp=105003769584&partnerID=8YFLogxK
U2 - 10.1016/j.jconrel.2025.113748
DO - 10.1016/j.jconrel.2025.113748
M3 - Article
C2 - 40252978
AN - SCOPUS:105003769584
SN - 0168-3659
VL - 382
JO - Journal of Controlled Release
JF - Journal of Controlled Release
M1 - 113748
ER -